Share on LinkedInShare on LinkedIn

ARTICLE · 21 MAY 2021

Patent Waiver For Covid-19 Vaccines – Necessary Or Reckless?

Kochhar & Co.
Kochhar & Co.
Contributor
Kochhar & Co.

Kochhar & Co.

Kochhar & Co has one of the largest full service commercial law practices in Bangalore. The firm...

View firm profile
Explore more from Kochhar & Co.

The world is in an upheaval now with the pandemic raging for over a year. The discussions and decisions that probably would never have been made a few years ago are being made today in the interest of the greater good and the public at large.

IndiaIntellectual Property

The world is in an upheaval now with the pandemic raging for over a year. The discussions and decisions that probably would never have been made a few years ago are being made today in the interest of the greater good and the public at large. When Bill Gates expressed his reservations against lifting IP protection on vaccine patents, it left the world reeling and his comments understandably criticised by experts and laymen alike. Several developing nations, including India, approached the World Trade Organisation (WTO) last year for approvals for the vaccine formula to be released to other manufacturers. A few days ago, we received further news that the United States supports a temporary lift on patents related to the Covid-19 vaccines and the Gates Foundation itself in an about face statement mentioned that they now support the opening of patents for the vaccine. All of this relates to the now growing concept of a Patent Waiver or an Open Patent.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from